SCHEMBL5378920

SCHEMBL5378920

CCOC(=O)[C@H](O)CNc1ccc(C2[C@H]3CS(=O)(=O)C[C@@H]23)c(F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
KCNQ4 P56696 1/20 0.34
KCNQ5 Q9NR82 1/20 0.34
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
MAPT P10636 3/20 0.31
MEN1 O00255 1/20 0.31
CASP3 P42574 1/20 0.31
KMT2A Q03164 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
DHODH Q02127 1/20 0.31
EPHX2 P34913 1/20 0.31
RAB9A P51151 2/20 0.31
NPC1 O15118 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14197158 1.00 KCNQ3 (0.34) KCNQ3KCNQ2KCNQ4KCNQ5ALDH1A1
SCHEMBL4876862 0.86 PTGS1 (0.31) ALDH1A1CYP3A4CYP2C9MAPT
SCHEMBL4876875 0.79 PTGS1 (0.31)
SCHEMBL5737719 0.73 DHODH (0.35) TRPV1DHODHEPHX2
SCHEMBL5378928 0.67 PTGS1 (0.31)
SCHEMBL6478024 0.67 ALDH1A1 (0.34) ALDH1A1RAB9A
SCHEMBL6478027 0.67 ALDH1A1 (0.34) ALDH1A1RAB9A
SCHEMBL3032800 0.67 L3MBTL1 (0.35) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL3032803 0.67 L3MBTL1 (0.35) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL5379509 0.66 MAOA (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7279494-B2 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues PFIZER INC. (US) 2007-10-09 US disclosed
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues RENSLO ADAM (US) 2005-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192325-A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues OXA1L, CYP51A1, CYP2C19 KCNQ3 2458/4885KCNQ2 2959/4885KCNQ4 3223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.